The Follow-up of Patients with Lung Cancer

被引：0
作者：
Tufman, Amanda [2 ,3 ]
Duell, Thomas [1 ]
Schneider, Christian [4 ]
机构：
[1] Asklepios Lungenfachkliniken Munchen Gauting, Klin Pneumol, Bereich Thorakale Onkol, Munich, Germany
[2] Univ Munich, Lungentumorzentrum Munchen, Munich, Germany
[3] Fachkliniken Munchen Gauting, Munich, Germany
[4] Klinikum Univ Munchen, Chirurg Klin & Poliklin, Bereich Thoraxchirurg, Klin Allgemein Viszeralchirurg, Campus Grosshadern, Munich, Germany
来源：
ZENTRALBLATT FUR CHIRURGIE | 2019年 / 144卷 / 01期
关键词：
BRAIN METASTASES; COMPUTED-TOMOGRAPHY; RISK-FACTORS; CELL; RECURRENCE; CHEMOTHERAPY; SURVEILLANCE; MANAGEMENT; RADIATION; DIAGNOSIS;
D O I：
10.1055/s-0043-111766
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：106 / 117
页数：12
相关论文
共 37 条
[1]  
[Anonymous], 2011, NICE clinical guideline 132 - Caesarean section
[2]   Survival Benefits from Follow-Up of Patients with Lung Cancer A Systematic Review and Meta-Analysis [J].
Calman, Lynn ;
Beaver, Kinta ;
Hind, Daniel ;
Lorigan, Paul ;
Roberts, Chris ;
Lloyd-Jones, Myfanwy .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (12) :1993-2004
[3]   Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall-cell lung cancer - Clinical implications for the subsequent management of the brain [J].
Chen, Allen M. ;
Jahan, Thierry M. ;
Jablons, David M. ;
Garcia, Joaquin ;
Larson, David A. .
CANCER, 2007, 109 (08) :1668-1675
[4]  
DOOD R, 2018, J CLIN ONCOL S, V36
[5]  
Ettinger DS, 2018, NONSMALL CELL LUNG C
[6]   Minimal-dose computed tomography is superior to chest x-ray for the follow-up and treatment of patients with resected lung cancer [J].
Hanna, Wael C. ;
Paul, Narinder S. ;
Darling, Gail E. ;
Moshonov, Hadas ;
Allison, Frances ;
Waddell, Thomas K. ;
Cypel, Marcelo ;
de Perrot, Marc E. ;
Yasufuku, Kazuhiro ;
Keshavjee, Shaf ;
Pierre, Andrew F. .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 147 (01) :30-35
[7]   Development of symptomatic brain metastases after chemoradiotherapy for stage III non-small cell lung cancer: Does the type of chemotherapy regimen matter? [J].
Hendriks, Lizza E. L. ;
Brouns, Anita J. W. M. ;
Amini, Mohammad ;
Uyterlinde, Wilma ;
Wijsman, Robin ;
Bussink, Jan ;
Biesma, Bonne ;
Oei, S. Bing ;
Stigt, Jos A. ;
Bootsma, Gerben P. ;
Belderbos, Jose S. A. ;
De Ruysscher, Dirk K. M. ;
Van den Heuvel, Michel M. ;
Dingemans, Anne-Marie C. .
LUNG CANCER, 2016, 101 :68-75
[8]  
Huber R M, 2017, MANUAL TUMOREN LUNGE
[9]   Second lung cancers in patients after treatment for an initial lung cancer [J].
Johnson, BE .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1998, 90 (18) :1335-1345
[10]   Prognostic Significance of Adenocarcinoma In Situ, Minimally Invasive Adenocarcinoma, and Nonmucinous Lepidic Predominant Invasive Adenocarcinoma of the Lung in Patients With Stage I Disease [J].
Kadota, Kyuichi ;
Villena-Vargas, Jonathan ;
Yoshizawa, Akihiko ;
Motoi, Noriko ;
Sima, Camelia S. ;
Riely, Gregory J. ;
Rusch, Valerie W. ;
Adusumilli, Prasad S. ;
Travis, William D. .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (04) :448-460
1234